Mayo Clinic finds surgeon caseload, practice setting affect treatment of small kidney tumors
May 15, 2011 in CancerPatients with small kidney tumors are more likely to be offered treatment options based on surgeons' case volume and type of practice than on tumor characteristics, a Mayo Clinic study has found. Fellowship-trained surgeons who practice in academic medical centers with high volumes of patients with kidney tumors were 70 to 80 percent more likely to follow American Urological Association (AUA) guidelines by recommending partial nephrectomy. Surgeons in private practice who see few patients with kidney tumors more often offered radical nephrectomy: removal of the entire kidney.
Mayo Clinic researchers presented their findings during the AUA Annual Meeting in Washington.
"There is wide variability in how renal masses are managed. We must recognize these discrepancies may be due to different perceptions of technical feasibility in performing a partial nephrectomy," says Christopher Weight, M.D., of Mayo Clinic's Department of Urology. "What we're encouraging is a discussion between physicians and patients about all options available. Some patients may benefit from a referral to surgeons with more experience with renal tumors."
The study shows that as kidney tumors get larger and more complex, all surgeons tend to offer a radical nephrectomy. However, the tumor complexity that may result in one surgeon recommending total removal of the kidney may be well below a more experienced surgeon's threshold. Approximately 45,000 Americans require radical or partial nephrectomy each year.
Provided by
Mayo Clinic
-
How less can be more when treating some kidney cancers
Jan 09, 2008 |
not rated yet |
0
-
Kidney cancer surgery often determined by surgeons' practice style, not medical factors
Mar 10, 2008 |
not rated yet |
0
-
Henry Ford Hospital sees improved results for more kidney patients through robotic surgery
Mar 01, 2011 |
not rated yet |
0
-
Limiting blood flow interruption during kidney surgery avoids chronic kidney disease
Jun 11, 2010 |
not rated yet |
0
-
Ablation proved as effective as traditional surgery in treating kidney cancer
Jun 02, 2010 |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (3) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Your brain on 'shrooms: fMRI elucidates neural correlates of psilocybin psychedelic state
Feb 29, 2012 |
4.9 / 5 (42) |
45
-
A question about drug tolerance
4 hours ago
-
Poor nutrition leading to overeating?
22 hours ago
-
Math and dyslexia?
May 21, 2012
-
portable metabolism meter?
May 21, 2012
-
Rare medical conditions on 20/20 tonight
May 18, 2012
-
"Good" Cholesterol in Doubt
May 17, 2012
- More from Physics Forums - Medical Sciences
More news stories
Cancer docs often deal with own grief, doubts when patients die
(HealthDay) -- Some cancer doctors may build up emotional walls -- distancing themselves from the patients they can't save -- to avoid grief, sadness and even despair, new research shows.
Cancer
9 hours ago |
not rated yet |
0
|
Regorafenib active in metastatic GI stromal tumors
(HealthDay) -- Regorafenib, an inhibitor of multiple cancer-associated kinases, is active in patients with metastatic gastrointestinal stromal tumors (GIST) who have failed to respond to imatinib and sunitinib, ...
Cancer
9 hours ago |
not rated yet |
0
Robotic-assisted prostate cancer surgery drives up costs
In one of the most comprehensive analyses to date of the cost of robotic-assisted, laparoscopic surgery for prostate cancer, researchers at UPMC found that this now-dominant surgical approach is significantly more costly ...
Cancer
11 hours ago |
not rated yet |
0
Cardio fitness levels of breast cancer patients may affect survival
Women receiving care for breast cancer have significantly impaired cardio-pulmonary function that can persist for years after they have completed treatment, according to a study led by scientists at Duke University Medical ...
Cancer
11 hours ago |
not rated yet |
0
|
Breast MRI helps predict chemotherapy's effectiveness
Magnetic resonance imaging (MRI) provides an indication of a breast tumor's response to pre-surgical chemotherapy significantly earlier than possible through clinical examination, according to a new study published online ...
Cancer
18 hours ago |
not rated yet |
0
The Goldilocks effect: Babies learn from experiences that are 'just right'
Long before babies understand the story of Goldilocks, they have more than mastered the fairy tale heroine's method of decision-making. Infants ignore information that is too simple or too complex, focusing instead on situations ...
Aspirin may prevent recurrence of deep vein blood clots
(HealthDay) -- After suffering a type of blood clot called a venous thromboembolism, patients usually take a blood-thinner such as warfarin (Coumadin). But aspirin may do just as well after a period of time, ...
Intrauterine devices, implants most effective birth control
A study to evaluate birth control methods has found dramatic differences in their effectiveness. Women who used birth control pills, the patch or vaginal ring were 20 times more likely to have an unintended pregnancy than ...
Study shows how immune cells change wiring of the developing mouse brain
Researchers have shown in mice how immune cells in the brain target and remove unused connections between brain cells during normal development. This research, supported by the National Institutes of Health, sheds light on ...
Women trying to have babies face different clock problem
A new Northwestern University study shows that the biological clock is not the only clock women trying to conceive should consider. The circadian clock needs attention, too.
Whole genome sequencing of rare olfactory neuroblastoma
The Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare have conducted whole genome sequencing (WGS) of a rare nasal tract cancer called olfactory neuroblastoma ...